Topical Ropivacaine Combined With Dexamethasone Spray Relieves Post‐Tonsillectomy Pain in Adults
The Laryngoscope · 2025
DOI: 10.1002/lary.32350 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift The Laryngoscope, 2025. Verfasst von Zhi-Qiang Zhang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otorhinolaryngology, Head and Neck Surgery, The Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, Chi…. Hauptthemen laut MEDLINE: Dexamethasone, Postoperative Pain, Tonsillectomy, Anesthetics, Local. Die Arbeit nennt 38 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Objective
To evaluate the efficacy of ropivacaine with dexamethasone spray for postoperative pain relief in adults undergoing tonsillectomy.
Methods
A total of 172 adult patients were randomly assigned to four groups: RD group ( n = 43) received topical 1% ropivacaine with dexamethasone spray, RP group ( n = 43) received topical 1% ropivacaine spray, Saline group ( n = 43) received topical saline spray, and Control group ( n = 43): not receive any interventions. The groups were compared on resting pain scores at 1, 2, 3, 5, 7, and 10 days, changes in pain scores over 10 days, adverse reactions (including dizziness, nausea, difficulty opening the mouth, and pharyngeal foreign body sensation), the time to first solid food intake, the time to first oral pain medication, and total pain medication dosage within 10 days postoperatively.
Results
The RD group had significantly lower resting pain scores at 1, 2, 3, 5, 7, and 10 days compared to the other groups, as well as a greater decrease in pain scores over 10 days, correlated with Body Mass Index (BMI) and independent of age. They also had earlier postoperative oral intake of solid food, reduced need for remedial analgesics, and lower incidence of difficulty opening the mouth, halitosis, and pharyngeal foreign body sensation compared to the RP, Saline, and Control groups.
Conclusion
Topical 1% ropivacaine with dexamethasone spray is easy to administer for postoperative tonsillar pain relief in adults. The dosage can be adjusted to meet patient needs, effectively addressing pain with fewer side effects, making it clinically useful and applicable. Level of Evidence: 2.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Otorhinolaryngology, Head and Neck Surgery, The Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, China.
- Department of Clinical Medicine, The First Clinical Medical College, Nanchang University, Nanchang, China.
- Department of Gastrointestinal Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
- Department of Orthopaedics, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
- Department of Critical Care Medicine, Medical Center of Anesthesiology and Pain, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, China.
- Department of Otolaryngology, Yanbian University Hospital, Yanji, China.
ORCID-Profile: Xin-Hua Zhu
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Zhang, Z. Q., Li, J. Y., Bao, Y. W., Song, Y. Q., Li, D. X., Wang, C., Ge, S. T., & Zhu, X. H. (2025). Topical Ropivacaine Combined With Dexamethasone Spray Relieves Post‐Tonsillectomy Pain in Adults. The Laryngoscope. https://doi.org/10.1002/lary.32350
Vancouver
Zhang ZQ, Li JY, Bao YW, Song YQ, Li DX, Wang C, et al. Topical Ropivacaine Combined With Dexamethasone Spray Relieves Post‐Tonsillectomy Pain in Adults. The Laryngoscope. 2025. doi:10.1002/lary.32350
BibTeX
@article{Zhang2025,
author = {Zhang, Zhi-Qiang and Li, Jing-Yang and Bao, You-Wei and Song, Yu-Qi and Li, Dong-Xu and Wang, Cheng and Ge, Si-Tong and Zhu, Xin-Hua},
title = {Topical Ropivacaine Combined With Dexamethasone Spray Relieves Post‐Tonsillectomy Pain in Adults},
journal = {The Laryngoscope},
year = {2025},
doi = {10.1002/lary.32350}
}
EUVIMED